SkyAI (SKYAI) and Bio Protocol (BIO) each posted gains of roughly 42% over the last 24 hours, landing together on CoinGecko's trending list on May 3, 2026.
The dual appearance of an AI-themed token and a decentralized-science token on the same trending page is uncommon for a low-volume overnight session.
The Numbers Behind the Move
SKYAI traded at $0.507 at the time of this scan. Its market cap stood at approximately $505M, putting it at rank 105 on CoinGecko. Daily volume reached $181M, a ratio of roughly 36 cents in volume for every dollar of market cap.
BIO traded at $0.0581. Its market cap sat at $124.5M, ranking it 254th globally. Volume was notably heavier relative to size, with $571.7M in 24-hour turnover against a market cap of $124.5M.
That ratio exceeds 4x, placing BIO among the highest volume-to-market-cap tokens in the top 300 during this window.
Both tokens gained approximately the same percentage in USD terms, 42.66% for SKYAI and 42.66% for BIO, suggesting coordinated buying pressure rather than isolated catalysts.
Also Read: ORDI Posts 35% Gain In 24 Hours With $202M In Daily Volume
What Each Project Does
SKYAI positions itself within the on-chain AI agent narrative. The project does not publish a detailed whitepaper in the CoinGecko data available at scan time, and no primary corporate blog or PR wire was located. It launched in early 2026 and reached a market cap above $500M within weeks of listing.
Bio Protocol sits in the decentralized science category. It describes itself as a funding and governance layer for biotech research, allowing token holders to direct capital toward scientific projects that traditional venture capital has historically passed over.
BIO launched in late 2024 and spent its first months below $50M in market cap before the DeSci narrative picked up traction in Q1 2026.
Also Read: Ondo, TAO, And ZK Lead A Quiet DeFi And AI Trending Session On May 2
Prior Context
The DeSci sector drew its first wave of mainstream crypto attention in late 2024. Bio Protocol was among the earliest tokens to benefit. In early 2025, BIO briefly reached $0.20 before retracing with the broader market. The token spent most of Q1 2026 rebuilding volume, and the 44% rally recorded two hours before this scan marked its strongest single-day move since that initial spike.
SKYAI has a shorter history. The AI agent narrative began compressing into a smaller set of tokens in March and April 2026, as several early AI coins lost liquidity. SKYAI attracted fresh inflows during that consolidation window. Its current $505M market cap places it ahead of BIO by roughly 4x in size, despite the similar percentage move.
Also Read: Decentralized AI Network Bittensor Sees TAO Rise As Sector Momentum Builds
Why These Two Are Moving Together
The AI and DeSci narratives overlap in one important way. Both are science-infrastructure stories. AI tokens attract buyers who want exposure to compute and model infrastructure on-chain.
DeSci tokens attract buyers who want exposure to research funding and intellectual property on-chain. In a low-volume session, capital rotating out of larger-cap AI plays sometimes lands in both categories simultaneously.
The parallel gain percentage is the clearest signal that buying was coordinated in timing, even if the underlying buyer motivation differs. No shared partnership, protocol integration, or joint announcement was identified in available signals for this session.
Also Read: Centrifuge CFG Token Sees $6.1M Volume During RWA Sector Momentum
What to Watch
BIO's volume-to-market-cap ratio above 4x is unsustainable over multiple sessions. Either the price continues climbing to match volume, or volume falls back to a more typical 0.2-0.5x range. The former would require sustained new buying. The latter is the more common outcome after a single-session spike.
SKYAI has more market cap buffer, but its thinner documentation creates uncertainty around catalysts. Traders watching for follow-through should monitor whether either token appears on the trending list again in the next 12-24 hours.
Read Next: Unipeg Climbs 115% With Volume Exceeding Market Cap